China Resources Boya Bio-pharmaceutical Group Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from China Resources Boya Bio-pharmaceutical Group Co Ltd
Access all reports
China Resources Boya Bio-pharmaceutical Group Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and distribution of plasma-derived biopharmaceutical products. The company's offerings include a range of products for immune system support, blood coagulation, and other therapeutic uses. China Resources Boya operates production facilities and leverages advanced bioprocessing technologies to ensure high standards in the manufacturing and quality control of its products. In addition to its focus on healthcare needs, the company also engages in initiatives aimed at expanding its biopharmaceutical pipeline. China Resources Boya Bio-pharmaceutical Group is headquartered in Chengdu, China, and its shares are listed on the Shenzhen Stock Exchange.
Key slides for China Resources Boya Bio-pharmaceutical Group Co Ltd
H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd
H1 2024
China Resources Boya Bio-pharmaceutical Group Co Ltd
Latest articles
What Investors Get Wrong: Chris Mayer on Dividends, Noise, and the Power of Reinvestment
Chris Mayer challenges investor myths on dividends, market noise, and the reinvestment edge. A deep dive into long-term thinking.
29 Nov 2024
Evolution: The Live Casino Juggernaut
With ~49% CAGR since its 2015 IPO, 60%+ EBIT margin, and global dominance in live casino, the story of Evolution is truly one for the books.
22 Nov 2024
House of Warhammer: The Inner Workings of Games Workshop
A look under the hood of Games Workshop, a high-margin business in an incredibly niche market, with sky-high stock returns.
15 Nov 2024
Ticker symbol
300294
Country
🇨🇳 China